
This autoimmune disease causes hair loss in both women and men, affecting 160 million people worldwide

More than 11,000 people are diagnosed with head and neck cancers every year in England

The deal will support the advancement of BioNTech’s mRNA-based cancer immunotherapies

BioNTech’s BNT327 is being evaluated in multiple clinical trials, including phase 3 studies in first-line lung cancer

The UK government has also agreed to award the company a grant of up to £129m

The updated vaccine was shown to generate an improved response against currently circulating variants

Adapted vaccines from Pfizer/BioNTech and Moderna have been authorised for individuals aged six months and older

The combined vaccine approach could simplify immunisation practices and lead to higher uptake

Melanoma is currently responsible for around 58,000 deaths globally every year

The vaccine generated an improved response against several Omicron JN.1 sublineages

The expansion builds on the companies’ strategic alliance previously announced in 2021

Both companies will leverage their autologous CAR-T cell therapy programmes